CTRI/2019/12/022284
Not yet recruiting
未知
Identification of Circulating Tumor DNA Mutations in Indian Lung Cancer Patients
DST INSPIRE Fellowship0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: C34- Malignant neoplasm of bronchus andlung
- Sponsor
- DST INSPIRE Fellowship
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed with lung cancer
- •Age less than 75 years and more than 18 years
- •Patients who are willing to give informed consent
Exclusion Criteria
- •HIV positive lung cancer patients
- •Patients with seriously ill conditions and major co\-morbidities
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Genomic Study of Lung CancerCTRI/2019/01/017085TMAI PAI ENDOWMENT CHAIR
Recruiting
Not Applicable
Quantification of Circulating tumor DNA to assess treatment response in metastatic prostate cancer patientsmetastatic prostate cancerNL-OMON24467Erasmus Medical Center95
Recruiting
Not Applicable
Identification of individual cancer mutations and analysis of their immunogenicitycancerC00-C97Malignant neoplasmsDRKS00011790BioNTech SE1,000
Recruiting
Not Applicable
Circulating Tumour DNA as a Sensitive and Specific Marker of Response to Therapy and of Occult Disease in Colorectal CancerPatients with resectable colorectal cancer liver metastasesCancer - Bowel - Back passage (rectum) or large bowel (colon)ACTRN12612000345886udwig Institute for Cancer Research100
Recruiting
Not Applicable
Circulating tumor DNA for minimal residual disease in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant: a multi-center prospective study.Acute Myeloid Leukemia, Myelodysplastic SyndromesJPRN-UMIN000033003Kanto Study Group for Cell Therapy70